FILTER RESULTS
FILTER RESULTS
close.svg
Search Result for “AstraZeneca”

Showing 1 - 10 of 85

OPINION

Growth requires getting PPPs right

Oped, Mariana Mazzucato, Published on 03/01/2025

» The United Kingdom's Labour government has given serious thought to the public investment needed to get the economy back on track after 14 years of austerity, neglect of social infrastructure, and capital flight triggered by Brexit and uncertain economic conditions.

OPINION

Unlocking health technology's potential for all

Oped, Mariana Mazzucato, Published on 09/11/2023

» Covid-19 cases are on the rise again, offering a stark reminder of the lessons we ought to have learned from previous waves. Far from being confined to Covid, most of these lessons apply to infectious-disease threats generally.

OPINION

How to finance the needs of the common good

Oped, Mariana Mazzucato, Published on 05/05/2023

» The Internationa Monetary Fund (IMPF) and the World Bank recently held their annual spring meetings, which, according to the organisers, produced a "strong message of confidence and a willingness to cooperate". But lofty rhetoric and good intentions will not be enough to create a truly inclusive and sustainable economy fit for the 21st century. For that, deep structural change is needed.

OPINION

Making parental leave work

Oped, Jon Åström Gröndahl, Published on 09/06/2022

» Sweden was the first country in the world to introduce paid parental leave to both mothers and fathers, doing so as early as 1974. Parents in Sweden are entitled to 480 days of paid parental leave when a child is born or adopted. Of these, 390 days can be distributed as parents see fit, allowing for flexible use until the child is eight years old.

OPINION

US move affects Africa's vax drive

Oped, Ebere Okereke, Published on 07/06/2022

» The US Food and Drug Administration's recent decision to limit the use of the Johnson & Johnson Covid-19 vaccine to adults who cannot or will not get another vaccine will have profound consequences for African countries. The FDA said its move reflected the risk that the vaccine might cause a rare blood-clotting syndrome. But the decision shows that, even after two years of the pandemic, the needs of people in low- and middle-income countries, and Africans in particular, remain an afterthought for leading global health authorities.

OPINION

Sort out the boosters

Oped, Editorial, Published on 15/12/2021

» With the new coronavirus strain Omicron lurking around the corner, booster jabs are to be expedited. But as Thailand has administered quite a few mix-and-match vaccination formulae, the public health authorities must quickly clarify what type of vaccine can be safely administered as booster shots for which formula.

OPINION

Reopening a good bet with high costs

Oped, Thitinan Pongsudhirak, Published on 12/11/2021

» Nearly two weeks into Thailand's official reopening during the Covid-19 pandemic, it is time to evaluate the country's vaccine management plan, economic costs and prospects of recovery. While the reopening is worth the attendant risks, Thailand is paying a disproportionately high price for earlier mistakes and the government's mismanagement. As the reopening phase builds up, the Thai economy is likely to see a weak and tentative recovery trajectory with medium-term challenges and question marks.

OPINION

Were we misled?

Oped, Postbag, Published on 05/11/2021

» Re: "Anti-Covid pill budget sought, migrants to get jabs," (BP, Nov 3).

OPINION

Masked question

Oped, Postbag, Published on 06/10/2021

» Re: "Covid lessons from abroad", (Editorial, Oct 4).

OPINION

Too dam costly

Oped, Postbag, Published on 02/10/2021

» Re: "Dams fail but still vital", (BP, Sept 26).